Features & Benefits
- Broad Coverage:
Utilizes more than 200 antibodies to develop 3-D conformational fingerprint.
- Intelligent Database:
Data analysis is supported by extensive databank containing 150+ innovator and biosimilar fingerprints.
- Artificial Intelligence Driven Data Analysis
- Glycan Profiling
- Predictive of Functional Activities:
- Target binding
- ADCC and CDC activity
- Fc Receptor binding
Intelli.b – Biosimilar Fingerprinting Technology
Somru BioScience has developed Intelli.b™ – a platform for the comparability testing of biosimilars at a molecular level that meets the intent of the FDA guidance for fingerprint-like analysis. The Intelli.b™ platform is an integrated, multi-parameter approach that is extremely sensitive in identifying analytical differences (i.e. fingerprint-like analysis).
Application of Intelli.b
Harness power of laboratory automation to boost your drug development studies.
Learn.
Engage.
Connect.
Learn | Engage | Connect
Read news, updates, and transforming technologies of drug development
17 March 2025 AI-Driven
17 March AI-Driven Compliance Webinar Our technical leaders would love..
Read More ...Mitigating target interference challenges
Now Streaming On-Demand Dr. Kamala’s presentation, “Mitigating Target Interference Challenges..
Read More ...Register Now
Webinar Registration Form
Read More ...UltraSensative
Amplatto™- Ultrasensitive Bioanalysis and Machine Learning
Read More ...